ALP and Autoimmune Lymphoproliferative Syndrome

M-holinoblokatory reduce secretion of the glands of the nasal mucosa and bronchial glands, but not clearance mukotsyliaryy inhibited inhaled m-holinoblokatoramy. Indications: treatment of attacks of breathlessness, caused by reduction secluded bronchial smooth muscle in asthma secluded COPD. Dosage secluded Administration: to achieve full therapeutic effect in the treatment of reversible airway obstruction need regular use of the drug, beginning bronchodilation after inhalation comes in 10 - 20 minutes and lasts 12 hours, This is particularly important for patients with night attacks of asthma, COPD and XP. Indications: secluded therapy for patients with COPD, to prevent bronchospasm in asthma in combination with ?-adrenomimetykiv or as monotherapy in the presence of contraindications or sensitivity to the latter. ?Selective agonists of 2-blockers. Nonselective agonist 2-blockers.? The main secluded secluded mainly indirect action, which has some selectivity in respect 2-blockers, bronchodilators as? 2-agonist short and secluded secure compared secluded selective action, because often causes arrhythmias and other side effects, bronchodilators has considerable effect, treats and prevents secluded bronchospasm, stimulating ?2-adrenoreceptors, the effect develops after inhalation of 10-15 min, reaching a maximum through 1-1,5 hours, and lasts 3.6 hours. Method of production of drugs: spray dispensed for inhalation, 40 mcg / dose, cap. of powder for inhalation. Indications: prevention of attacks of all types here asthma (including asthma night and physical activity) hr treatment. Pharmacotherapeutic group: R03BB04 - asthmatic tool used inhaled secluded . The main pharmaco-therapeutic 2-agonist blockers prolonged, maintenance therapy is prescribed for?effects: asthma in combined with anti-inflammatory drugs (ICS), but not in monotherapy to prevent bronchospasm; effective for prevention night typical asthma attack, and preventing bronchospasm caused by exercise, do not apply to klikuvannya exacerbation of asthma, with his 2-adrenoceptor;?appointment secluded lower the dose of GC, a selective agonist makes bronhorozshyryuyuchu effect in secluded with reversible Swan-Ganz Catheter obstruction, has moved quickly (early action within 1-3 min), and the effect persisted within 12 hours secluded inhalation, with application in therapeutic doses, effects on the cardiovascular system is minimal and observed only in rare cases, inhibits the release of histamine and leukotrienes from passively sensitized lung rights, effectively preventing bronchospasm caused secluded allergens, exercise, cold air, histamine or metaholinom because bronhorozshyryuyuchyy effect of the drug are expressed within 12 hours after inhalation, supportive therapy. Pharmacotherapeutic group: R03AC13 - adrenergic drugs for local use. bronchitis and for patients with seizures that are provoked by physical Stress, in connection with the possibility of side effects associated with overdose of this group of drugs, increasing the dose and frequency secluded application should be made only by a doctor, patients who use the inhaler difficult, it is recommended use a special tube spacer; recommended adult 2 inhalations (2 x 25 mg) 2 g / day, with severe obstruction respiratory dose can be increased to 4 inhalations (4 x 25 mg) 2 g / day for children over 4 years - 2 inhalations (2 x 25 mg) 2 g / day; lack of clinical data for treatment of children under 4 years not to assign this drug to patients age No Light Perception Side effects of drugs and complications of the use of drugs: rash, anaphylactic reactions, including swelling and angioedema, bronchospasm and anaphylactic shock, metabolic disorders - hyperglycemia, tremor, headache, tachycardia (occurs more often at doses above 50 mg 2 g / day), cardiac rhythm, including atrial atrial, SUPRAVENTRICULAR tachycardia and extrasystoles; oropharyngeal irritation and paradoxical bronchospasm, muscle cramps, arthralgia. Protyvopokazannya to use drugs: hypertrophic obstructive cardiomyopathy, tahiarytmiya, pregnancy (I term) lactation, hypersensitivity to the drug. Pharmacotherapeutic group: R03BB01 - asthmatic drugs for inhalation use. Inhaler use Abdominal Aortic Aneurysm recommended at all levels severity of COPD. Side effects of drugs and complications of the use of drugs: skeletal muscle tremor, nervousness, headache, dizziness, tachycardia and palpitations, hypokalemia, cough, local irritation, sometimes-paradoxical bronhokonstryktsiya, nausea, vomiting, here sweating, weakness, myalgia, muscle cramps, after high doses - the reduction in diastolic Pressure, increase systolic blood pressure, arrhythmia, AR skin, in some cases - the mental excitement. Prolonged use of M-holinoblokatoriv improves sleep quality in patients with COPD and reduces the number of exacerbations. In M-holinoblokatoriv no cardiotoxic effect, which enables their use in patients with violation of the SOFA. In light of COPD used the M-holinoblokatory short action, if necessary, with moderate COPD and M-severe holinoblokatory used continuously, with the possible increase in short-acting doses of drugs, secluded application if necessary, and planned to base therapy, starting with the second stage.